Home / Events / The importance of EGFR CDx testing and recent treatment updates in early stage NSCLC

The importance of EGFR CDx testing and recent treatment updates in early stage NSCLC

Moderator

Dr. Espen Walker

Medical and Scientific Affairs Oncology, Roche Diagnostics Asia Pacific

Speakers

Dr. Noemi Reguart

Medical Oncologist, Hospital Clinic Barcelona, Spain

Dr. Shanop Shuangshoti

Professor, Pathology, Chulalongkorn University, Thailand

This content is targeted at healthcare professionals and could contain information otherwise not accessible, approved or valid in your country. Please be aware that we do not take any responsibility for you accessing information which may not comply with any legal process, regulation, registration or usage in the country of your origin.This content is for general information purposes only. We disclaim all liability and are not responsible for any third party content on our website or which our website links to.